Development, validation and application of a questionnaire to qualify the indoor environmental exposure of patients with respiratory allergy

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Citação
JOURNAL OF ASTHMA, v.60, n.6, p.1191-1201, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective Environmental control includes measures to prevent exposure to common aeroallergens in an individual's home. Questionnaires are part of the clinical practice of health assessment, and are also widely used in research. Our aim was to develop and validate a questionnaire to identify possible sources of aeroallergens present in the indoor environment. Methods This study describes the development, validation and application of a questionnaire. For content validation the Content Validation Index and Ordinal Cronbach's Alpha Index have been used; Polychoric Correlations for the agreement between judges; and an Exploratory Factor Analysis for the structure of the questionnaire, while for reliability assessment, Intraclass Correlation Coefficient has been applied. Results Twenty-one doctors participated as judges to validate the questionnaire, which 204 patients answered. The Content Validity Index for all the questions on the ""Clarity"" aspect was 0.846 +/- 0.152 and on the ""Relevance"" aspect, 0.954 +/- 0.080. Cronbach's alpha coefficient for the ""Clarity"" aspect was 0.88 with a 95% confidence intervals (CI) and the ""Relevance"" aspect, 0.94 with a 95% CI. The average Intraclass Correlation Coefficient was 0.94 and all the F tests were highly significant. Conclusions The questionnaire developed by our group was considered valid and reliable, and is capable of portraying the home environment without the need for a personal visit to the patient's home. This questionnaire would be a good tool to use in research or during patient consultations to assess the patient's home environment, as this latter assessment is essential for the management of patients with respiratory allergies.
Palavras-chave
Respiratory allergy, aeroallergens, atopy, asthma, environmental control, indoor environmental exposure, questionnaires, validation
Referências
  1. Abu Khweek A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.534501
  2. Ahluwalia SK, 2018, J ALLER CL IMM-PRACT, V6, P9, DOI 10.1016/j.jaip.2017.10.009
  3. Akar-Ghibril N, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00941-5
  4. Akar-Ghibril N, 2020, J ALLER CL IMM-PRACT, V8, P429, DOI 10.1016/j.jaip.2019.11.008
  5. Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24
  6. Blanco-Aparicio M, 2021, ARCH BRONCONEUMOL, V57, P383, DOI [10.1016/j.arbres.2020.08.019, 10.1016/j.arbr.2021.04.004]
  7. Boateng GO, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00149
  8. Boynton PM, 2004, BRIT MED J, V328, P1312, DOI 10.1136/bmj.328.7451.1312
  9. Fernandez LC, 2013, ARCH BRONCONEUMOL, V49, P22, DOI 10.1016/j.arbres.2012.04.005
  10. Celebi Sozener Z., 2022, FRONT ALLERGY, V3
  11. Cipriani F, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00103
  12. CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297, DOI 10.1007/BF02310555
  13. Czira A, 2022, RESP MED, V191, DOI 10.1016/j.rmed.2021.106670
  14. Delclos GL, 2006, OCCUP ENVIRON MED, V63, P173, DOI 10.1136/oem.2005.021634
  15. Cancado JED, 2019, J ASTHMA, V56, P244, DOI 10.1080/02770903.2018.1445267
  16. Diette Gregory B, 2008, Respir Care, V53, P602
  17. Global Initiative for Asthma, 2022, GLOB STRAT ASTHM MAN
  18. Gonzalez-Barcala FJ, 2013, ARCH ENVIRON OCCUP H, V68, P66, DOI 10.1080/19338244.2011.638950
  19. Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC
  20. Hedman L, 2022, ERJ OPEN RES, V8, DOI 10.1183/23120541.00074-2022
  21. Hsiao HP, 2019, J ALLER CL IMM-PRACT, V7, P556, DOI 10.1016/j.jaip.2018.08.008
  22. Indinnimeo L, 2016, INT J IMMUNOPATH PH, V29, P308, DOI 10.1177/0394632016635656
  23. Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591
  24. Liccardi G, 2005, RESP MED, V99, P1363, DOI 10.1016/j.rmed.2005.03.012
  25. Lombardi C, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-016-0138-8
  26. Melo Rosane M. Barreto de, 2005, J. bras. pneumol., V31, P5, DOI 10.1590/S1806-37132005000100003
  27. Mogensen I, 2022, ERJ OPEN RES, V8, DOI 10.1183/23120541.00154-2022
  28. Platts-Mills TAE, 2007, J ALLERGY CLIN IMMUN, V119, P297, DOI 10.1016/j.jaci.2006.12.647
  29. PLATTSMILLS TAE, 1982, LANCET, V2, P675
  30. Pleasants RA, 2020, ANN AM THORAC SOC, V17, P804, DOI 10.1513/AnnalsATS.202002-133VP
  31. Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147
  32. SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
  33. Sockrider Marianna, 2022, Am J Respir Crit Care Med, V205, pP25, DOI 10.1164/rccm.20512P25
  34. Thomas Mike, 2009, Prim Care Respir J, V18, P41, DOI 10.4104/pcrj.2009.00010
  35. van Boven FE, 2019, CLIN EXP ALLERGY, V49, P400, DOI 10.1111/cea.13340
  36. Wilson JM, 2018, J ALLER CL IMM-PRACT, V6, P1, DOI 10.1016/j.jaip.2017.10.003
  37. World Health Organization, 2011, ASTHMA
  38. World Health Organization, 2021, OB OV